BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SHR-4685 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SHR-4685\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07676903-11116@assetmemo.bio
DTSTAMP:20261121T004548Z
DTSTART;VALUE=DATE:20281031
DTEND;VALUE=DATE:20281101
SUMMARY:SHR-4685: Phase 1 readout est. (NCT07676903)
DESCRIPTION:SHR-4685\, phase 1.\nStudy: A Clinical Study of SHR-4685 on Saf
 ety\, Tolerability and Pharmacokinetics in Participants With Solid Tumors\
 nEstimated primary completion: October 2028. This is a ClinicalTrials.gov 
 estimate\, not a confirmed readout date\, and it can move.\nDrug page: htt
 ps://assetmemo.bio/drug/shr-4685#upcoming-events\nRegistry record: https:/
 /clinicaltrials.gov/study/NCT07676903
URL:https://assetmemo.bio/drug/shr-4685#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
